NASDAQ:APOP - Nasdaq -
NASDAQ:APOP (10/28/2021, 8:24:41 PM)
13.17
+0.05 (+0.38%)
The current stock price of APOP is 13.17 null. In the past month the price decreased by -28.66%. In the past year, price increased by 81.91%.
Cellect Biotechnology Ltd. offers biomedical services. It provides stem cell transplantation, disease management, regenerative medicine, clinical research and other services. Cellect Biotechnology Ltd. is based in TEL AVIV, Israel.
Cellect Biotechnology Ltd ADR
23 HATA`AS STREET
KFAR SABA L3 44425
CEO: Shai Yarkoni
Phone: 972-9974-1444
The current stock price of APOP is 13.17 null. The price increased by 0.38% in the last trading session.
The exchange symbol of Cellect Biotechnology Ltd ADR is APOP and it is listed on the Nasdaq exchange.
APOP stock is listed on the Nasdaq exchange.
Cellect Biotechnology Ltd ADR (APOP) has a market capitalization of 12.87M null. This makes APOP a Nano Cap stock.
Cellect Biotechnology Ltd ADR (APOP) has a support level at 13. Check the full technical report for a detailed analysis of APOP support and resistance levels.
The Revenue of Cellect Biotechnology Ltd ADR (APOP) is expected to grow by 5% in the next year. Check the estimates tab for more information on the APOP EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
APOP does not pay a dividend.
Cellect Biotechnology Ltd ADR (APOP) does not have a PE ratio as the earnings reported over the last twelve months were negative (-6).
ChartMill assigns a technical rating of 2 / 10 to APOP. When comparing the yearly performance of all stocks, APOP is one of the better performing stocks in the market, outperforming 72.18% of all stocks.
ChartMill assigns a fundamental rating of 1 / 10 to APOP. APOP has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months APOP reported a non-GAAP Earnings per Share(EPS) of -6. The EPS increased by 34.78% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -155.68% | ||
ROE | N/A | ||
Debt/Equity | 0 |